Breath test aims to classify leukaemia in hours, not days
Diagnosis
Not yet recruiting
Doctors often wait days for genetic tests to classify acute myeloid leukaemia (AML) and guide treatment. This trial tests whether breath analysis can detect metabolic products from leukaemia and classify the disease faster. Participants give breath samples and extra blood tests d…
Sponsor: Jeremy Deuel • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC